Necrotizing enterocolitis: Preventative strategies

Clinics in Perinatology

Volumn 31, Issue 1, 2004, Pages 157-167

  Reber, Kristina M ^a   Nankervis, Craig A ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GENTAMICIN; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; KANAMYCIN; PROBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BREAST MILK; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; FEEDING BEHAVIOR; FETUS LUNG MATURATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION PREVENTION; LACTOBACILLUS; LOW BIRTH WEIGHT; NECROTIZING ENTEROCOLITIS; NUTRITIONAL SUPPORT; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; PROTEIN DIET; REVIEW;

ADMINISTRATION, ORAL; AMINO ACIDS; ANIMALS; ANTI-BACTERIAL AGENTS; DIETARY SUPPLEMENTS; DUCTUS ARTERIOSUS, PATENT; ENTEROCOLITIS, NECROTIZING; FOOD DEPRIVATION; HUMANS; IMMUNOGLOBULINS; INFANT, NEWBORN; INFANT, PREMATURE; MILK, HUMAN; PRENATAL CARE; PREVENTIVE MEDICINE; PROBIOTICS; STEROIDS;

EID: 2942538112     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2004.03.002     Document Type: Review

References (86)

1. Stoll B. Epidemiology of necrotizing enterocolitis. Clin Perinatol. 21:1994;205-219
2. Kliegman R., Fanaroff A. Neonatal necrotizing enterocolitis. N Engl J Med. 310:1984;1093-1103
3. Hopkins G., Gould V., Stevenson J., Oliver T. Necrotizing enterocolitis in preterm infants: a clinical and pathologic evaluation of autopsy material. Am J Dis Child. 120:1970;229-232
4. Crissinger K.D., Granger D.N. Characterization of intestinal collateral blood flow in the developing piglet. Pediatr Res. 24:1988;473-476
5. Kliegman R.M., Walsh M.C. Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Prob Pediatr. 17:1987;213-288
6. Kanto W.P., Hunter J.E., Stoll B.J. Recognition and medical management of necrotizing enterocolitis. Clin Perinatol. 21:1994;335-346
7. Kosloske A.M., Musemeche C.A. Necrotizing enterocolitis of the neonate. Clin Perinatol. 16:1989;97-111
8. Cikrit D., Mastandrea J., West K.W., Schreiner R.L., Grosfeld J.L. Necrotizing enterocolitis: factors affecting mortality in 101 surgical cases. Surgery. 96:1984;648-655
9. Stevenson D.K., Kerner J.A., Malachowski N., Sunshine P. Late morbidity among survivors of necrotizing enterocolitis. Pediatrics. 66:1980;925-927
10. Sonntag J., Grimmer I., Scholz T., Metze B., Wit J., Obladen M. Growth and neurodevelopmental outcome of very low birthweight infants with necrotizing enterocolitis. Acta Paediatr. 89:2000;528-532
11. Stanford A., Upperman J.S., Boyle P., Schall L., Ojimba J.I., Ford H.R. Long term follow-up of patients with necrotizing enterocolitis. J Pediatr Surg. 37:2002;1048-1050
12. Brown E.G., Sweet A.Y. Preventing necrotizing enterocolitis in neonates. JAMA. 240:1978;2452-2454
13. Rothman D., Udall J.N., Pang K.Y., Kirkham S.E., Walker W.A. The effect of short-term starvation on mucosal barrier function in the newborn rabbit. Pediatr Res. 19:1985;727-731
14. Dunn L., Hulman S., Weiner J., Kliegman R. Beneficial effects of early hypocaloric enteral feeding on neonatal gastrointestinal function: preliminary report of a randomized trial. J Pediatr. 112:1988;622-629
15. Kennedy K.A., Tyson J.E., Chamnanvanikij S. Early versus delayed initiation of progressive enteral feedings for parenterally fed low birth weight or preterm infants. Cochrane Database Syst Rev. 2:2000;CD001970
16. Rayyis S.F., Ambalavanan N., Wright L., Carlo W.A. Randomized trial of "slow" versus "fast" feed advancements on the incidence of necrotizing enterocolitis in very low birth weight infants. J Pediatr. 134:1999;293-297
17. Kennedy K.A., Tyson J.E., Chamnanvanakij S. Rapid versus slow rate of advancement of feedings for promoting growth and preventing necrotizing enterocolitis in parenterally fed low-birth-weight infants. Cochrane Database Syst Rev. 2:2000;CD001241
18. Williams A.F. Early enteral feeding of the preterm infant. Arch Dis Child Fetal Neonatal Ed. 83:2000;F219-F220
19. La Gamma E.F., Browne L.E. Feeding practices for infants weighing less than 1500 G at birth and the pathogenesis of necrotizing enterocolitis. Clin Perinatol. 21:1994;271-306
20. Berseth C.L., Bisquera J.A., Paje V.U. Prolonging small feeding volumes early in life decreases the incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 111:2003;529-534
21. Kliegman R.M. The relationship of neonatal feeding practices and the pathogenesis and prevention of necrotizing enterocolitis. Pediatrics. 111:2003;671-672
22. Ward R.M. Pharmacologic enhancement of fetal lung maturation. Clin Perinatol. 21:1994;523-542
23. Neu J., Ozaki C.K., Angelides K.J. Glucocorticoid-mediated alteration of fluidity of brush border membrane in rat small intestine. Pediatr Res. 20:1986;79-82
24. Bauer C.R., Morrison J.C., Poole W.K., Korones S.B., Boehm J.J., Rigatto H., et al. A decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy. Pediatrics. 73:1984;682-688
25. Halac E., Halac J., Begue E.F., Casanas J.M., Indiveri D.R., Petit J.F., et al. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. J Pediatr. 117:1990;132-138
26. Smith L.M., Qureshi N., Chao C.R. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks' gestation. J Matern Fetal Med. 9:2000;131-135
27. Uauy R.D., Fanaroff A.A., Korones S.B., Phillips E.A., Phillips J.B., Wright L.L. Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr. 119:1991;630-638
28. Kamitsuka M.D., Horton M.K., Williams M.A. The incidence of necrotizing enterocolitis after introducing standardized feeding schedules for infants between 1250 and 2500 grams and less than 35 weeks of gestation. Pediatrics. 105:2000;379-384
29. Guthrie S.O., Gordon P.V., Thomas V., Thorp J.A., Peabody J., Clark R.H. Necrotizing enterocolitis among neonates in the United States. J Perinatol. 23:2003;278-285
30. Burgio G.R., Lanzavecchia A., Plebani A., Jayakar S., Ugazio A.G. Ontogeny of secretory immunity: levels of secretory IgA and natural antibodies in saliva. Pediatr Res. 14:1980;1111-1114
31. Udall J.N., Walker W.A. Mucosal defense mechanisms. Marsh M.N. Immunopathology of the small intestine. 1987;3 John Wiley and Sons, London
32. Eibl M.M., Wolf H.M., Furnkranz H., Rosenkranz A. Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. N Engl J Med. 319:1988;1-7
33. Rubaltelli F.F., Benini F., Sala M. Prevention of necrotizing enterocolitis in neonates at risk by oral administration of monomeric IgG. Dev Pharmacol Ther. 17:1991;138-143
34. Fast C., Rosegger H. Necrotizing enterocolitis prophylaxis: oral antibiotics and lyophilized enterobacteria vs oral immunoglobulins. Acta Paediatr Suppl. 396:1994;86-90
35. Richter D., Bartmann P., Pohlandt F. Prevention of necrotizing enterocolitis in extremely low birth weight infants by IgG feeding? Eur J Pediatr. 15:1998;924-925
36. Foster J., Cole M. Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth-weight neonates. Cochrane Database Syst Rev. 1:2001;CD001816
37. Ohlsson A., Lacy J.B. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev. 1:2001;CD000361
38. Crissinger K.D. Regulation of hemodynamics and oxygenation in developing intestine: insight into the pathogenesis of necrotizing enterocolitis. Acta Paediatr Suppl. 396:1994;8-10
39. Nowicki P. Intestinal ischemia and necrotizing enterocolitis. J Pediatr. 117:1990;S14-S19
40. Nankervis C.A., Nowicki P.T. Role of nitric oxide in regulation of vascular resistance in postnatal intestine. Am J Physiol. 268:1995;G949-G958
41. Reber K.M., Mager G.M., Miller C.E., Nowicki P.T. Relationship between flow rate and NO production in postnatal mesenteric arteries. Am J Physiol. 280:2001;G43-G50
42. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 43:1991;109-142
43. Stark M.E., Szurszewski J.H. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology. 102:1992;1928-1949
44. Alican I., Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol. 270:1996;G225-G237
45. Palmer R.M., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666
46. Zamora S.A., Amin H.J., McMillan D.D., Kubes P., Fick G.H., Butzner J.D., et al. Plasma L-arginine concentrations in premature infants with necrotizing enterocolitis. J Pediatr. 131:1997;226-232
47. Becker R.M., Wu G., Galanko J.A., Chen W., Maynor A.R., Bose C.L., et al. Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr. 137:2000;785-793
48. Di Lorenzo M., Bass J., Krantis A. Use of L-arginine in the treatment of experimental necrotizing enterocolitis. J Pediatr Surg. 30:1995;235-240
49. Akisu M., Ozmen D., Baka M., Habif S., Yalaz M., Arslanoglu S., et al. Protective effect of dietary supplementation with L-arginine and L-carnitine on hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice. Biol Neonate. 81:2002;260-265
50. Irat A.M., Aktan F., Ozansoy G. Effects of L-carnitine treatment on oxidant/antioxidant state and vascular reactivity of streptozotocin-diabetic rat aorta. J Pharm Pharmacol. 55:2003;1389-1395
51. Amin H.J., Zamora S.A., McMillan D.D., Fick G.H., Butzner J.D., Parsons H.G., et al. Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr. 140:2002;425-431
52. Egan E.A., Mantilla G., Nelson R.M., Eitzman D.V. A prospective controlled trial of oral kanamycin in the prevention of neonatal necrotizing enterocolitis. J Pediatr. 89:1976;467-470
53. Boyle R., Nelson J.S., Stonestreet B.S., Peter G., Oh W. Alterations in stool flora resulting from oral kanamycin prophylaxis of necrotizing enterocolitis. J Pediatr. 93:1978;857-861
54. Grylack L.J., Scanlon J.W. Oral gentamicin therapy in the prevention of neonatal necrotizing enterocolitis: a controlled double-blind trial. Am J Dis Child. 32:1978;1192-1194
55. Rowley M.P., Dahlenburg G.W. Gentamicin in prophylaxis of neonatal necrotising enterocolitis. Lancet. 2:1978;532
56. Siu Y.K., Ng P.C., Fung S.C., Lee C.H., Wong M.Y., Fok T.F., et al. Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 79:1998;F105-F109
57. Bury R.G., Tudehope D. Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. Cochrane Database Syst Rev. 1:2001;CD000405
58. Ryder R.W., Shelton J.D., Guinan M.E. Necrotizing enterocolitis: a prospective multicenter investigation. Am J Epidemiol. 112:1980;113-123
59. Cassady G., Crouse D.T., Kirklin J.W., Strange M.J., Joiner C.H., Godoy G., et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med. 320:1989;1511-1516
60. Nestrud R.M., Hill D.E., Arrington R.W., Beard A.G., Dungan W.T., Lau P.Y., et al. Indomethacin treatment in patent ductus arteriosus: a double-blind study utilizing indomethacin plasma levels. Dev Pharmacol Ther. 1:1980;125-136
61. Yanagi R.M., Wilson A., Newfeld E.A., Aziz K.U., Hunt C.E. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study. Pediatrics. 67:1981;647-652
62. Fowlie P.W. Prophylactic indomethacin: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 74:1996;F81-F87
63. Fowlie P.W., Davis P.G. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 88:2003;F464-F466
64. Grosfeld J.L., Chaet M., Molinari F., Engle W., Engum S.A., West K.W., et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg. 224:1996;350-355
65. O'Donovan D.J., Baetiong A., Adams K., Chen A., Smith E.O., Adams J.M., et al. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus. J Perinatol. 23:2003;286-290
66. Cooke L., Steer P., Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2:2003;CD003745
67. Barlow B., Santulli T.V., Heird W.C., Pitt J., Blanc W.A., Schullinger J.N. An experimental study of acute neonatal enterocolitis: the importance of breast milk. J Pediatr Surg. 9:1974;587-595
68. Schanler R.J., Shulman R.J., Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics. 103:1999;1150-1157
69. Lucas A., Cole T.J. Breast milk and neonatal necrotizing enterocolitis. Lancet. 336:1990;1519-1523
70. Ledbetter D.J., Juul S.E. Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. J Pediatr Surg. 35:2000;178-181
71. Dvorak B., Halpern M.D., Holubec H., Dvorakova K., Dominguez J.A., Williams C.S., et al. Maternal milk reduces severity of necrotizing enterocolitis and increases IL-10 in a neonatal rat model. Pediatr Res. 53:2003;426-433
72. Dvorak B., Halpern M.D., Holubec H., Williams C.S., McWilliam D.L., Dominguez J.A., et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol. 282:2002;G156-G164
73. Caplan M.S., Jilling T. The pathophysiology of necrotizing enterocolitis. NeoReviews. 2:2001;103-108
74. Caplan M.S., Lickerman M., Adler L., Dietsch G., Yu A. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr Res. 42:1997;779-783
75. Caplan M.S., Sun X.M., Hseuh W., Hageman J.R. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr. 116:1990;960-964
76. Furukawa M., Lee E.L., Johnston J.M. Platelet-activating factor-induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase. Pediatr Res. 34:1993;237-241
77. Caplan M.S., Russell T., Xiao Y., Amer M., Kaup S., Jilling T. Effect of polyunsaturated fatty acid (PUFA) supplementation on intestinal inflammation and necrotizing enterocolitis (NEC) in a neonatal rat model. Pediatr Res. 49:2001;647-652
78. Carpenter G., Cohen S. Epidermal growth factor. J Biol Chem. 265:1990;7709-7712
79. Miettinen P.J., Berger J.E., Meneses J., Phung Y., Pedersen R.A., Werb Z., et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature. 376:1995;337-341
80. Shin C.E., Falcone R.A., Stuart L., Erwin C.R., Warner B.W. Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg. 35:2000;173-176
81. Iacopetta B.J., Grieu F., Harisberger M., Sunahara G.I. Epidermal growth factor in human and bovine milk. Acta Paediatr. 81:1992;287-291
82. Collins M.D., Gibson G.R. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr. 69:1999;1052S-1057S
83. Millar M., Wilks M., Costeloe K. Probiotics for preterm infants? Arch Dis Child Fetal Neonatal Ed. 88:2003;F354-F358
84. Caplan M.S., Miller-Catchpole R., Kaup S., Russell T., Lickerman M., Amer M., et al. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology. 117:1999;577-583
85. Butel M.J., Waligora-Dupriet A.J., Szylit O. Oligofructose and experimental model of neonatal necrotising enterocolitis. Br J Nutr. 87:2002;S213-S219
86. Hoyos A.B. Reduced incidence of necrotizing enterocolitis associated with enteral administration of lactobacillus acidophilus and bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis. 3:1999;197-202